NO20052023L - Kalsium aktivert K kanal apner med hoy konduktans - Google Patents

Kalsium aktivert K kanal apner med hoy konduktans

Info

Publication number: NO20052023L
Authority: NO; Norway
Prior art keywords: calcium activated; alkyl; ring; heterocyclic group; substituted
Prior art date: 2002-10-15

Application number

NO20052023A

Other languages

English (en)

Norwegian (no)

Inventor

Rikako Kono

Toshihiro Hosaka

Mari Kusama

Kiyomi Ohba

Shuntarou Kohnomi

Original Assignee

Tanabe Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-15

Filing date

2005-04-26

Publication date

2005-05-10

2005-04-26 Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co

2005-05-10 Publication of NO20052023L publication Critical patent/NO20052023L/no

Links

OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title abstract 2
229910052791 calcium Inorganic materials 0.000 title abstract 2
239000011575 calcium Substances 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 3
125000000623 heterocyclic group Chemical group 0.000 abstract 3
125000003118 aryl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Hydrogenated Pyridines (AREA)

NO20052023A 2002-10-15 2005-04-26 Kalsium aktivert K kanal apner med hoy konduktans NO20052023L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002300860		2002-10-15
JP2003104260		2003-04-08
PCT/JP2003/013194 WO2004035570A1 (en)	2002-10-15	2003-10-15	Large conductance calcium-activated k channel opener

Publications (1)

Publication Number	Publication Date
NO20052023L true NO20052023L (no)	2005-05-10

Family

ID=32109456

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052023A NO20052023L (no)	2002-10-15	2005-04-26	Kalsium aktivert K kanal apner med hoy konduktans

Country Status (20)

Country	Link
US (1)	US7531655B2 (is)
EP (1)	EP1556376B1 (is)
JP (1)	JP4657917B2 (is)
KR (1)	KR100744358B1 (is)
CN (1)	CN1705659A (is)
AR (1)	AR041616A1 (is)
AT (1)	ATE401324T1 (is)
BR (1)	BR0315386A (is)
CA (1)	CA2501979A1 (is)
DE (1)	DE60322245D1 (is)
ES (1)	ES2309340T3 (is)
IS (1)	IS7745A (is)
MX (1)	MXPA05003972A (is)
NO (1)	NO20052023L (is)
NZ (1)	NZ539902A (is)
PL (1)	PL375890A1 (is)
RU (1)	RU2005114524A (is)
TW (1)	TWI271402B (is)
WO (1)	WO2004035570A1 (is)
ZA (1)	ZA200503023B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070167499A1 (en) *	2003-10-27	2007-07-19	A*Bio Pte Ltd.	Biaryl linked hydroxamates: preparation and pharmaceutical applications
JP2005325103A (ja) *	2004-04-13	2005-11-24	Tanabe Seiyaku Co Ltd	医薬組成物
US20080293788A1 (en) *	2004-06-14	2008-11-27	Sullivan Anne M	Methods and Compositions for the Treatment of Pulmonary Diseases
CA2570386A1 (en) *	2004-06-14	2005-12-29	Sepracor Inc.	Methods of using albuterol and calcium activated potassium channel openers
TW200616969A (en) *	2004-09-17	2006-06-01	Tanabe Seiyaku Co	Imidazole compound
WO2008051197A2 (en)	2005-09-20	2008-05-02	Mayo Foundation For Medical Education And Research	Small-molecule botulinum toxin inhibitors
US8575338B2 (en) *	2008-04-09	2013-11-05	Mitsubishi Tanabe Pharma Corporation	Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers
WO2013009259A1 (en) *	2011-07-14	2013-01-17	Biochromix Pharma Ab	Novel compounds and their use in therapy
FR2993563B1 (fr)	2012-07-20	2015-12-18	Metabrain Res	Derives de thiophenes utiles dans le traitement du diabete

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1271082A (en) *	1968-05-07	1972-04-19	Wyeth John & Brother Ltd	Furan, pyrrole and thiophene derivatives
US3743656A (en)	1969-05-01	1973-07-03	Wyeth John & Brother Ltd	Thiophene and furan lower alkanoic acids and derivatives
US5062169A (en)	1990-03-09	1991-11-05	Leggett & Platt, Incorporated	Clinical bed
EP0565296B1 (en)	1992-04-07	1996-08-07	Neurim Pharmaceuticals (1991) Limited	Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia
WO1996010567A1 (en) *	1994-09-30	1996-04-11	Maruho Co., Ltd.	Aminoketone derivative, physiologically acceptable salt thereof, and use of the same
AT402926B (de) *	1994-12-05	1997-09-25	Hafslund Nycomed Pharma	Heterocyclische amide, verfahren zu ihrer herstellung und verwendung
CA2223918C (en)	1995-06-07	2006-01-10	Nippon Shinyaku Co., Ltd.	Pyrrole derivatives and medicinal composition
US5565483A (en) *	1995-06-07	1996-10-15	Bristol-Myers Squibb Company	3-substituted oxindole derivatives as potassium channel modulators
JPH09278751A (ja) *	1996-04-12	1997-10-28	Taisho Pharmaceut Co Ltd	ピペラジン誘導体
TW467902B (en)	1996-07-31	2001-12-11	Bristol Myers Squibb Co	Diphenyl heterocycles as potassium channel modulators
US5869195A (en)	1997-01-03	1999-02-09	Exxon Research And Engineering Company	Corrosion resistant carbon steel
PT853083E (pt) *	1997-01-06	2001-12-28	Pfizer	Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
EP0922043B1 (en) *	1997-04-24	2002-01-30	Dow AgroSciences LLC	Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles
US6020339A (en) *	1997-10-03	2000-02-01	Merck & Co., Inc.	Aryl furan derivatives as PDE IV inhibitors
JPH11302270A (ja) *	1998-04-22	1999-11-02	Dainippon Pharmaceut Co Ltd	１−〔（５−置換−２−フリル）メチル〕環状アミン誘導体及び関連化合物
JP2000351773A (ja)	1999-06-08	2000-12-19	Yamanouchi Pharmaceut Co Ltd	フラン誘導体からなる医薬
IT1320771B1 (it)	2000-10-26	2003-12-10	Enichem Spa	Leganti tridentati e relativi complessi con metalli di transizione.
US7759373B2 (en)	2001-04-16	2010-07-20	Mitsubishi Tanabe Pharma Corporation	Large conductance calcium-activated K channel opener

2003
- 2003-10-14 TW TW92128367A patent/TWI271402B/zh not_active IP Right Cessation
- 2003-10-15 US US10/531,330 patent/US7531655B2/en not_active Expired - Fee Related
- 2003-10-15 CN CNA2003801015080A patent/CN1705659A/zh active Pending
- 2003-10-15 ES ES03754140T patent/ES2309340T3/es not_active Expired - Lifetime
- 2003-10-15 JP JP2005501348A patent/JP4657917B2/ja not_active Expired - Fee Related
- 2003-10-15 KR KR1020057006418A patent/KR100744358B1/ko not_active Expired - Fee Related
- 2003-10-15 EP EP03754140A patent/EP1556376B1/en not_active Expired - Lifetime
- 2003-10-15 PL PL03375890A patent/PL375890A1/xx not_active Application Discontinuation
- 2003-10-15 MX MXPA05003972A patent/MXPA05003972A/es unknown
- 2003-10-15 CA CA002501979A patent/CA2501979A1/en not_active Abandoned
- 2003-10-15 NZ NZ539902A patent/NZ539902A/en unknown
- 2003-10-15 BR BR0315386-0A patent/BR0315386A/pt not_active IP Right Cessation
- 2003-10-15 AR ARP030103742A patent/AR041616A1/es not_active Application Discontinuation
- 2003-10-15 AT AT03754140T patent/ATE401324T1/de not_active IP Right Cessation
- 2003-10-15 RU RU2005114524/04A patent/RU2005114524A/ru not_active Application Discontinuation
- 2003-10-15 WO PCT/JP2003/013194 patent/WO2004035570A1/en not_active Ceased
- 2003-10-15 DE DE60322245T patent/DE60322245D1/de not_active Expired - Lifetime
- 2003-12-15 ZA ZA200503023A patent/ZA200503023B/en unknown
2005
- 2005-03-15 IS IS7745A patent/IS7745A/is unknown
- 2005-04-26 NO NO20052023A patent/NO20052023L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2309340T3 (es)	2008-12-16
CA2501979A1 (en)	2004-04-29
WO2004035570A1 (en)	2004-04-29
TWI271402B (en)	2007-01-21
EP1556376A1 (en)	2005-07-27
PL375890A1 (en)	2005-12-12
BR0315386A (pt)	2005-08-23
ZA200503023B (en)	2006-11-29
KR100744358B1 (ko)	2007-07-30
DE60322245D1 (de)	2008-08-28
RU2005114524A (ru)	2006-02-27
US7531655B2 (en)	2009-05-12
AU2003272099A1 (en)	2004-05-04
JP4657917B2 (ja)	2011-03-23
JP2006503111A (ja)	2006-01-26
NZ539902A (en)	2007-05-31
CN1705659A (zh)	2005-12-07
US20060135597A1 (en)	2006-06-22
IS7745A (is)	2005-03-15
TW200418844A (en)	2004-10-01
EP1556376B1 (en)	2008-07-16
MXPA05003972A (es)	2005-06-22
AR041616A1 (es)	2005-05-26
KR20050057654A (ko)	2005-06-16
ATE401324T1 (de)	2008-08-15

Legal Events

Date	Code	Title	Description
2009-05-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20060219L (no)	2006-04-28	Forbindelser
NO20083684L (no)	2004-05-03	Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
EA200601852A1 (ru)	2007-04-27	Тетрагидрохинолиновые производные и способ их получения
ATE377004T1 (de)	2007-11-15	Proteinkinaseinhibitoren
DE60331187D1 (de)	2010-03-25	Kinaseinhibitoren
MXPA06001274A (es)	2006-04-11	Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
NO20054852L (no)	2005-12-13	GFAT inhibitorer
DE60328010D1 (de)	2009-07-30	Heterocyclische verbindungen
ATE324371T1 (de)	2006-05-15	N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
DK1585739T3 (da)	2011-06-20	Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
EA200600925A1 (ru)	2006-12-29	Производные триазола в качестве антагонистов вазопрессина
MX2009012283A (es)	2009-11-25	Derivado heterociclico que contiene nitrogeno que tiene actividad inhibitoria de 11beta-hidroxiesteroide-deshidrogenasa tipo 1.
TW200642689A (en)	2006-12-16	Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
NO20091590L (no)	2009-05-08	Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
NO20082136L (no)	2008-06-30	1,5-substituerte indol-2-yl-amidderivater
WO2007149448A3 (en)	2008-02-21	Pyrazinones as cellular proliferation inhibitors
NO20071258L (no)	2007-06-18	Imidazolforbindelser.
NO20063576L (no)	2006-10-06	1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
MXPA05013631A (es)	2006-02-24	Derivado heterociclico de metilsulfona.
NO20052023L (no)	2005-05-10	Kalsium aktivert K kanal apner med hoy konduktans
NO20064175L (no)	2006-12-13	Heterosyklisk forbindelse
NO20073758L (no)	2007-10-19	2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som CGRP-antagonister
HRP20070286T3 (en)	2007-08-31	Substituted diketopiperazines and their use as oxytocyn antagonists
TW200738145A (en)	2007-10-16	Pesticidal mixtures
TW200626130A (en)	2006-08-01	5-membered heterocycle derivatives